We opted for bringing the IMCD-specialists and treatment centres in contact with each other. We achieved this by setting up a peer-to-peer network with KOLs and asked whether they would take the lead. On LinkedIn an IMCD-group was established where the KOLs together with Eusapharma are manager. The aim of the LinkedIn-group is to exchange knowledge and science concerning IMCD with the healthcare professionals involved in IMCD treatment in an accessible manner and through a central location.
In order to achieve attention for IMCD among a broader audience, an animation was made and spread both online and offline. In addition an accredited course was developed in which specialized centres explain making a diagnosis, treatment, patient care paths and practical experience.
The LinkedIn-group caused the establishment of a durable network of physicians that is still active and sharing knowledge.